4//SEC Filing
Covidien plc 4
Accession 0001225208-13-024117
CIK 0001385187operating
Filed
Nov 21, 7:00 PM ET
Accepted
Nov 22, 4:03 PM ET
Size
8.4 KB
Accession
0001225208-13-024117
Insider Transaction Report
Form 4
Covidien plcCOV
BRUST ROBERT H
Director
Transactions
- Sale
Ordinary Shares
2013-11-21$66.68/sh−10,521$701,496→ 8,217 total - Exercise/Conversion
Stock Option (Right to Buy)
2013-11-21−10,521→ 0 totalExercise: $39.32Exp: 2017-07-02→ Ordinary Shares (10,521 underlying) - Exercise/Conversion
Ordinary Shares
2013-11-21$39.32/sh+10,521$413,686→ 18,738 total
Footnotes (3)
- [F1]The price reported is the weighted average price. Shares were sold in multiple transactions at prices ranging from $66.6610 to $66.6850. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a securityholder of the Issuer, full information regarding the number of shares sold at each price.
- [F2]Adjusted in connection with the spin-off of Covidien's pharmaceuticals business.
- [F3]Options became exercisable in equal installments on each of the first, second, third and fourth anniversary of the grant date.
Documents
Issuer
Covidien plc
CIK 0001385187
Entity typeoperating
Related Parties
1- filerCIK 0001385187
Filing Metadata
- Form type
- 4
- Filed
- Nov 21, 7:00 PM ET
- Accepted
- Nov 22, 4:03 PM ET
- Size
- 8.4 KB